Characterization of the proline-utilization pathway in Mycobacterium tuberculosis through structural and functional studies

Thomas Lagautriere, Ghader Bashiri, Neil G. Paterson, Michael Berney, Gregory M. Cook, Edward N. Baker

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The proline-utilization pathway in Mycobacterium tuberculosis (Mtb) has recently been identified as an important factor in Mtb persistence in vivo, suggesting that this pathway could be a valuable therapeutic target against tuberculosis (TB). In Mtb, two distinct enzymes perform the conversion of proline into glutamate: the first step is the oxidation of proline into Δ1-pyrroline-5-carboxylic acid (P5C) by the flavoenzyme proline dehydrogenase (PruB), and the second reaction involves converting the tautomeric form of P5C (glutamate-γ-semialdehyde) into glutamate using the NAD+-dependent Δ1-pyrroline-5-carboxylic dehydrogenase (PruA). Here, the three-dimensional structures of Mtb-PruA, determined by X-ray crystallography, in the apo state and in complex with NAD+ are described at 2.5 and 2.1 Å resolution, respectively. The structure reveals a conserved NAD+-binding mode, common to other related enzymes. Species-specific conformational differences in the active site, however, linked to changes in the dimer interface, suggest possibilities for selective inhibition of Mtb-PruA despite its reasonably high sequence identity to other PruA enzymes. Using recombinant PruA and PruB, the proline-utilization pathway in Mtb has also been reconstituted in vitro. Functional validation using a novel NMR approach has demonstrated that the PruA and PruB enzymes are together sufficient to convert proline to glutamate, the first such demonstration for monofunctional proline-utilization enzymes.

Original languageEnglish (US)
Pages (from-to)968-980
Number of pages13
JournalActa Crystallographica Section D: Biological Crystallography
Volume70
Issue number4
DOIs
StatePublished - Apr 2014
Externally publishedYes

Fingerprint

Mycobacterium tuberculosis
Proline
Glutamic Acid
NAD
Enzymes
Carboxylic Acids
Proline Oxidase
X Ray Crystallography
Catalytic Domain
Oxidoreductases
Tuberculosis
pyrroline

Keywords

  • crystal disorder
  • Mycobacterium tuberculosis
  • proline utilization
  • PruA

ASJC Scopus subject areas

  • Structural Biology
  • Medicine(all)

Cite this

Characterization of the proline-utilization pathway in Mycobacterium tuberculosis through structural and functional studies. / Lagautriere, Thomas; Bashiri, Ghader; Paterson, Neil G.; Berney, Michael; Cook, Gregory M.; Baker, Edward N.

In: Acta Crystallographica Section D: Biological Crystallography, Vol. 70, No. 4, 04.2014, p. 968-980.

Research output: Contribution to journalArticle

Lagautriere, Thomas ; Bashiri, Ghader ; Paterson, Neil G. ; Berney, Michael ; Cook, Gregory M. ; Baker, Edward N. / Characterization of the proline-utilization pathway in Mycobacterium tuberculosis through structural and functional studies. In: Acta Crystallographica Section D: Biological Crystallography. 2014 ; Vol. 70, No. 4. pp. 968-980.
@article{1c5a2c92f9154be294d613b9da95a4e7,
title = "Characterization of the proline-utilization pathway in Mycobacterium tuberculosis through structural and functional studies",
abstract = "The proline-utilization pathway in Mycobacterium tuberculosis (Mtb) has recently been identified as an important factor in Mtb persistence in vivo, suggesting that this pathway could be a valuable therapeutic target against tuberculosis (TB). In Mtb, two distinct enzymes perform the conversion of proline into glutamate: the first step is the oxidation of proline into Δ1-pyrroline-5-carboxylic acid (P5C) by the flavoenzyme proline dehydrogenase (PruB), and the second reaction involves converting the tautomeric form of P5C (glutamate-γ-semialdehyde) into glutamate using the NAD+-dependent Δ1-pyrroline-5-carboxylic dehydrogenase (PruA). Here, the three-dimensional structures of Mtb-PruA, determined by X-ray crystallography, in the apo state and in complex with NAD+ are described at 2.5 and 2.1 {\AA} resolution, respectively. The structure reveals a conserved NAD+-binding mode, common to other related enzymes. Species-specific conformational differences in the active site, however, linked to changes in the dimer interface, suggest possibilities for selective inhibition of Mtb-PruA despite its reasonably high sequence identity to other PruA enzymes. Using recombinant PruA and PruB, the proline-utilization pathway in Mtb has also been reconstituted in vitro. Functional validation using a novel NMR approach has demonstrated that the PruA and PruB enzymes are together sufficient to convert proline to glutamate, the first such demonstration for monofunctional proline-utilization enzymes.",
keywords = "crystal disorder, Mycobacterium tuberculosis, proline utilization, PruA",
author = "Thomas Lagautriere and Ghader Bashiri and Paterson, {Neil G.} and Michael Berney and Cook, {Gregory M.} and Baker, {Edward N.}",
year = "2014",
month = "4",
doi = "10.1107/S1399004713034391",
language = "English (US)",
volume = "70",
pages = "968--980",
journal = "Acta Crystallographica Section D: Structural Biology",
issn = "0907-4449",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Characterization of the proline-utilization pathway in Mycobacterium tuberculosis through structural and functional studies

AU - Lagautriere, Thomas

AU - Bashiri, Ghader

AU - Paterson, Neil G.

AU - Berney, Michael

AU - Cook, Gregory M.

AU - Baker, Edward N.

PY - 2014/4

Y1 - 2014/4

N2 - The proline-utilization pathway in Mycobacterium tuberculosis (Mtb) has recently been identified as an important factor in Mtb persistence in vivo, suggesting that this pathway could be a valuable therapeutic target against tuberculosis (TB). In Mtb, two distinct enzymes perform the conversion of proline into glutamate: the first step is the oxidation of proline into Δ1-pyrroline-5-carboxylic acid (P5C) by the flavoenzyme proline dehydrogenase (PruB), and the second reaction involves converting the tautomeric form of P5C (glutamate-γ-semialdehyde) into glutamate using the NAD+-dependent Δ1-pyrroline-5-carboxylic dehydrogenase (PruA). Here, the three-dimensional structures of Mtb-PruA, determined by X-ray crystallography, in the apo state and in complex with NAD+ are described at 2.5 and 2.1 Å resolution, respectively. The structure reveals a conserved NAD+-binding mode, common to other related enzymes. Species-specific conformational differences in the active site, however, linked to changes in the dimer interface, suggest possibilities for selective inhibition of Mtb-PruA despite its reasonably high sequence identity to other PruA enzymes. Using recombinant PruA and PruB, the proline-utilization pathway in Mtb has also been reconstituted in vitro. Functional validation using a novel NMR approach has demonstrated that the PruA and PruB enzymes are together sufficient to convert proline to glutamate, the first such demonstration for monofunctional proline-utilization enzymes.

AB - The proline-utilization pathway in Mycobacterium tuberculosis (Mtb) has recently been identified as an important factor in Mtb persistence in vivo, suggesting that this pathway could be a valuable therapeutic target against tuberculosis (TB). In Mtb, two distinct enzymes perform the conversion of proline into glutamate: the first step is the oxidation of proline into Δ1-pyrroline-5-carboxylic acid (P5C) by the flavoenzyme proline dehydrogenase (PruB), and the second reaction involves converting the tautomeric form of P5C (glutamate-γ-semialdehyde) into glutamate using the NAD+-dependent Δ1-pyrroline-5-carboxylic dehydrogenase (PruA). Here, the three-dimensional structures of Mtb-PruA, determined by X-ray crystallography, in the apo state and in complex with NAD+ are described at 2.5 and 2.1 Å resolution, respectively. The structure reveals a conserved NAD+-binding mode, common to other related enzymes. Species-specific conformational differences in the active site, however, linked to changes in the dimer interface, suggest possibilities for selective inhibition of Mtb-PruA despite its reasonably high sequence identity to other PruA enzymes. Using recombinant PruA and PruB, the proline-utilization pathway in Mtb has also been reconstituted in vitro. Functional validation using a novel NMR approach has demonstrated that the PruA and PruB enzymes are together sufficient to convert proline to glutamate, the first such demonstration for monofunctional proline-utilization enzymes.

KW - crystal disorder

KW - Mycobacterium tuberculosis

KW - proline utilization

KW - PruA

UR - http://www.scopus.com/inward/record.url?scp=84898727266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898727266&partnerID=8YFLogxK

U2 - 10.1107/S1399004713034391

DO - 10.1107/S1399004713034391

M3 - Article

C2 - 24699642

AN - SCOPUS:84898727266

VL - 70

SP - 968

EP - 980

JO - Acta Crystallographica Section D: Structural Biology

JF - Acta Crystallographica Section D: Structural Biology

SN - 0907-4449

IS - 4

ER -